ConductScience.org, home

Library / Trials

A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department

NCT07916792, Not applicable, Not yet recruiting, University of Colorado, Denver

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleA Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency DepartmentClinicalTrials.gov
NCT numberNCT07916792ClinicalTrials.gov
StatusNot yet recruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment200 participants, estimatedClinicalTrials.gov
Lead sponsorUniversity of Colorado, DenverClinicalTrials.gov
ConditionsSuicidal Ideas, Suicidal Ideation, Suicidal Thoughts, Firearm SafetyClinicalTrials.gov
InterventionsTEEN LENS, Usual CareClinicalTrials.gov
First posted2026-11-04ClinicalTrials.gov
Last updated2026-11-06ClinicalTrials.gov

Registered outcomes 6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryAcceptability among teensWithin 48 hours of receipt of care (intervention or control).
Acceptability among teens during the intervention versus control period using the composite score from the adapted validated Client Satisfaction Questionnaire (CSQ-8), where higher scores indicate increased acceptability.
ClinicalTrials.gov
SecondaryAcceptability among caregiversWithin 48 hours of receipt of care (intervention or control).
Acceptability among caregivers during the intervention versus control period using the composite score from the adapted validated Client Satisfaction Questionnaire (CSQ-8), where higher scores indicate increased acceptability.
ClinicalTrials.gov
SecondaryProvider perceived acceptabilityFrom start of the intervention period until end of the intervention period (6 months).Provider perceived acceptability of using TEEN LENS ED using the validated Acceptability of Intervention Measure (AIM), a composite score where higher scores indicate higher acceptability.ClinicalTrials.gov
SecondaryProvider perceived appropriatenessFrom start of the intervention period until end of the intervention period (6 months).Provider perceived appropriateness using the validated Intervention Appropriateness Measure (IAM), a composite score where higher scores indicate higher appropriateness.ClinicalTrials.gov
SecondaryProvider perceived feasibilityFrom start of the intervention period until end of the intervention period (6 months).Provider perceived feasibility using the validated Feasibility of Intervention Measure (FIM), a composite score where higher scores indicate higher feasibility.ClinicalTrials.gov
SecondaryFeasibility of follow upFrom enrollment to follow up at 2 months.Proportion of participants who complete baseline surveys that complete follow up.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource
K23HD114903TEEN LENS ED: TEen ENgaged LEthal meaNS planning for the Emergency DepartmentHAASZ, MAYAUNIVERSITY OF COLORADO DENVEREUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT2024 to 2025NIH RePORTER

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)